| __timestamp | Dr. Reddy's Laboratories Limited | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 10337679 |
| Thursday, January 1, 2015 | 42585000000 | 18187286 |
| Friday, January 1, 2016 | 45702000000 | 24758063 |
| Sunday, January 1, 2017 | 46372000000 | 23666957 |
| Monday, January 1, 2018 | 46910000000 | 30099855 |
| Tuesday, January 1, 2019 | 48890000000 | 64947625 |
| Wednesday, January 1, 2020 | 50129000000 | 186363444 |
| Friday, January 1, 2021 | 54559000000 | 272611040 |
| Saturday, January 1, 2022 | 62081000000 | 358782000 |
| Sunday, January 1, 2023 | 105931000000 | 409864000 |
| Monday, January 1, 2024 | 77201000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, understanding spending patterns is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry players: Dr. Reddy's Laboratories Limited and Intra-Cellular Therapies, Inc., from 2014 to 2023.
Dr. Reddy's Laboratories, a global pharmaceutical giant, has shown a consistent upward trend in SG&A expenses, peaking at approximately 106% growth from 2014 to 2023. This reflects their expansive market strategies and operational scale. In contrast, Intra-Cellular Therapies, a smaller biotech firm, exhibited a staggering 3,860% increase in SG&A expenses over the same period, highlighting their aggressive investment in growth and market penetration.
While Dr. Reddy's expenses surged in 2023, Intra-Cellular's data for 2024 remains elusive, leaving room for speculation on their future financial strategies. This comparison underscores the diverse financial strategies within the pharmaceutical sector.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Intra-Cellular Therapies, Inc.
Operational Costs Compared: SG&A Analysis of GSK plc and Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Bio-Techne Corporation
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Geron Corporation Trends and Insights
Intra-Cellular Therapies, Inc. vs Xencor, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.